China National Accord Medicines Corp Ltd Cash Flow-to-Debt Ratio
China National Accord Medicines Corp Ltd cash flow-to-debt ratio. China National Accord Medicines Corp Ltd (000028) has a Cash Flow-to-Debt Ratio of -0.01x as of September 2025, meaning its operating cash flow of CN¥-425.23 Million could theoretically repay 0% of its total liabilities (CN¥29.01 Billion) in one year. Check China National Accord Medicines Corp Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of China National Accord Medicines Corp Ltd (1998–2024)
Cash flow-to-debt ratio of China National Accord Medicines Corp Ltd from 1998 to 2024. Historical debt coverage capacity for China National Accord Medicines Corp Ltd across 27 annual periods. Check 000028 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
China National Accord Medicines Corp Ltd Cash Flow-to-Debt Ratio by Year (1998–2024)
China National Accord Medicines Corp Ltd cash flow-to-debt ratio by year from 1998 to 2024. Year-by-year debt coverage analysis for China National Accord Medicines Corp Ltd. For the full cash flow conversion analysis, see cash flow conversion of China National Accord Medicines Corp Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.12x | CN¥3.27 Billion | CN¥26.80 Billion | ▲ +10.5% |
| 2023 | 0.11x | CN¥2.94 Billion | CN¥26.59 Billion | ▼ 0.0% |
| 2022 | 0.11x | CN¥2.56 Billion | CN¥23.17 Billion | ▲ +65.3% |
| 2021 | 0.07x | CN¥1.66 Billion | CN¥24.76 Billion | ▲ +1.0% |
| 2020 | 0.07x | CN¥1.50 Billion | CN¥22.71 Billion | ▼ -39.9% |
| 2019 | 0.11x | CN¥2.00 Billion | CN¥18.16 Billion | ▲ +25.1% |
| 2018 | 0.09x | CN¥1.32 Billion | CN¥15.02 Billion | ▼ -15.0% |
| 2017 | 0.10x | CN¥1.29 Billion | CN¥12.42 Billion | ▼ -12.8% |
| 2016 | 0.12x | CN¥1.47 Billion | CN¥12.40 Billion | ▼ -13.3% |
| 2015 | 0.14x | CN¥1.05 Billion | CN¥7.65 Billion | ▲ +237.1% |
| 2014 | -0.10x | CN¥-796.70 Million | CN¥7.98 Billion | ▼ -287.7% |
| 2013 | 0.05x | CN¥465.03 Million | CN¥8.74 Billion | ▲ +22.5% |
| 2012 | 0.04x | CN¥323.96 Million | CN¥7.46 Billion | ▲ +19.2% |
| 2011 | 0.04x | CN¥227.32 Million | CN¥6.24 Billion | ▼ -56.0% |
| 2010 | 0.08x | CN¥428.16 Million | CN¥5.18 Billion | ▲ +33.0% |
| 2009 | 0.06x | CN¥270.85 Million | CN¥4.36 Billion | ▼ -23.5% |
| 2008 | 0.08x | CN¥246.58 Million | CN¥3.03 Billion | ▲ +121.3% |
| 2007 | 0.04x | CN¥87.70 Million | CN¥2.39 Billion | ▼ -55.4% |
| 2006 | 0.08x | CN¥181.73 Million | CN¥2.21 Billion | ▼ -62.3% |
| 2005 | 0.22x | CN¥148.28 Million | CN¥678.73 Million | ▼ -18.2% |
| 2004 | 0.27x | CN¥130.30 Million | CN¥487.99 Million | ▲ +118.8% |
| 2003 | 0.12x | CN¥81.22 Million | CN¥665.47 Million | ▲ +204.6% |
| 2002 | 0.04x | CN¥28.76 Million | CN¥717.90 Million | ▼ -57.6% |
| 2001 | 0.09x | CN¥71.16 Million | CN¥753.72 Million | ▼ -4.9% |
| 2000 | 0.10x | CN¥8.52 Million | CN¥85.83 Million | ▼ -62.3% |
| 1999 | 0.26x | CN¥22.84 Million | CN¥86.72 Million | ▲ +477.0% |
| 1998 | 0.05x | CN¥5.21 Million | CN¥114.11 Million | — |